American Vanguard Co. (AVD) Insider Peter Porpiglia Sells 2,800 Shares

Share on StockTwits

American Vanguard Co. (NYSE:AVD) insider Peter Porpiglia sold 2,800 shares of American Vanguard stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $23.47, for a total transaction of $65,716.00. Following the transaction, the insider now directly owns 24,557 shares in the company, valued at $576,352.79. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of AVD traded up $0.10 during mid-day trading on Thursday, reaching $22.65. 87,342 shares of the stock traded hands, compared to its average volume of 110,107. The firm has a market capitalization of $691.39 million, a P/E ratio of 39.39 and a beta of 1.18. American Vanguard Co. has a 12-month low of $17.00 and a 12-month high of $24.00. The company has a quick ratio of 1.09, a current ratio of 2.15 and a debt-to-equity ratio of 0.29.

American Vanguard (NYSE:AVD) last posted its quarterly earnings data on Tuesday, May 8th. The basic materials company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.03. The company had revenue of $104.11 million for the quarter, compared to analyst estimates of $103.81 million. American Vanguard had a net margin of 5.52% and a return on equity of 6.01%. The business’s quarterly revenue was up 47.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.12 earnings per share. equities analysts expect that American Vanguard Co. will post 0.82 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 12th. Stockholders of record on Thursday, June 28th will be paid a dividend of $0.02 per share. The ex-dividend date of this dividend is Wednesday, June 27th. This represents a $0.08 dividend on an annualized basis and a dividend yield of 0.35%. American Vanguard’s dividend payout ratio is currently 14.04%.

AVD has been the topic of a number of recent research reports. Roth Capital reaffirmed a “buy” rating on shares of American Vanguard in a research report on Thursday, March 15th. Zacks Investment Research lowered shares of American Vanguard from a “hold” rating to a “sell” rating in a research note on Tuesday, March 20th. Finally, ValuEngine upgraded shares of American Vanguard from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $25.00.

Several institutional investors and hedge funds have recently bought and sold shares of AVD. Victory Capital Management Inc. raised its stake in shares of American Vanguard by 84.3% during the first quarter. Victory Capital Management Inc. now owns 13,468 shares of the basic materials company’s stock valued at $272,000 after purchasing an additional 6,161 shares during the period. MetLife Investment Advisors LLC bought a new stake in shares of American Vanguard in the fourth quarter worth $293,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of American Vanguard in the first quarter worth $355,000. Alps Advisors Inc. bought a new stake in shares of American Vanguard in the first quarter worth $420,000. Finally, Stone Ridge Asset Management LLC bought a new stake in shares of American Vanguard in the fourth quarter worth $438,000. Institutional investors own 77.30% of the company’s stock.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Axiom Price Reaches $0.0078 on Exchanges
Axiom Price Reaches $0.0078 on Exchanges
Starta Hits 24-Hour Trading Volume of $0.00
Starta Hits 24-Hour Trading Volume of $0.00
Zacks: Brokerages Expect MTS Systems Co.  Will Announce Earnings of $0.63 Per Share
Zacks: Brokerages Expect MTS Systems Co. Will Announce Earnings of $0.63 Per Share
Obalon Therapeutics  Getting Somewhat Positive Media Coverage, Study Shows
Obalon Therapeutics Getting Somewhat Positive Media Coverage, Study Shows
Novus Therapeutics  Receives News Impact Score of 0.16
Novus Therapeutics Receives News Impact Score of 0.16
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc  This Quarter
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc This Quarter


Leave a Reply

 
© 2006-2018 Zolmax.